Champions Oncology, Inc. (CSBR) 追踪市盈率为负值 -36.3, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 51.5 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -2.76%, 前瞻盈利收益率 1.94%.
本页证实的标准:
SharesGrow 综合评分： 51/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -3.2 | 0.16 | 140.66 | 2.99 | - |
| 2017 | -4.1 | 0.09 | 70.25 | 1.82 | - |
| 2018 | -32.3 | 0.41 | 15,882.88 | 2.35 | - |
| 2019 | 804.4 | -7.40 | 46.01 | 3.80 | - |
| 2020 | -43.7 | 0.03 | 17.93 | 2.85 | - |
| 2021 | 389.5 | -3.38 | 18.98 | 3.44 | - |
| 2022 | 185.0 | 3.67 | 11.14 | 2.06 | - |
| 2023 | -12.3 | 0.01 | 14.20 | 1.22 | - |
| 2024 | -9.0 | -0.23 | -34.53 | 1.31 | - |
| 2025 | 20.8 | -0.13 | 25.89 | 1.72 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-1.20 | $11.18M | $-10.45M | -93.4% |
| 2017 | $-0.63 | $15.41M | $-6.88M | -44.7% |
| 2018 | $-0.14 | $20.24M | $-1.51M | -7.4% |
| 2019 | $0.01 | $27.07M | $128K | 0.5% |
| 2020 | $-0.17 | $32.12M | $-1.98M | -6.1% |
| 2021 | $0.02 | $41.04M | $362K | 0.9% |
| 2022 | $0.04 | $49.11M | $548K | 1.1% |
| 2023 | $-0.39 | $53.87M | $-5.34M | -9.9% |
| 2024 | $-0.54 | $50.16M | $-7.28M | -14.5% |
| 2025 | $0.33 | $56.94M | $4.7M | 8.3% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $0.12 | $0.12 – $0.12 | $58.53M | $58.53M – $58.53M | 1 |
| 2027 | $0.10 | $0.10 – $0.10 | $65.26M | $65.26M – $65.26M | 1 |
| 2028 | $0.00 | $0.00 – $0.00 | $70.81M | $70.81M – $70.81M | 0 |
